These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 2275277)

  • 21. [Experimental study of subcutaneous and aerosol vaccination against the plaque in cynocephalous monkeys. Absence of correlation between hemagglutination and precipitant antibodies and protection].
    Fournier J; Paul G; Chomel J; Dodin A; Fontanges R
    Ann Microbiol (Paris); 1973 Oct; 124(3):315-28. PubMed ID: 4791964
    [No Abstract]   [Full Text] [Related]  

  • 22. Immunogenicity of plague vaccines in mice and guinea pigs.
    von Metz E; Eisler DM; Hottle GA
    Appl Microbiol; 1971 Jul; 22(1):84-8. PubMed ID: 5111306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Virulence factors of Yersinia pestis are overcome by a strong lipopolysaccharide response.
    Montminy SW; Khan N; McGrath S; Walkowicz MJ; Sharp F; Conlon JE; Fukase K; Kusumoto S; Sweet C; Miyake K; Akira S; Cotter RJ; Goguen JD; Lien E
    Nat Immunol; 2006 Oct; 7(10):1066-73. PubMed ID: 16980981
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Early protection of animals, immunized by a recombinant plague vaccine, from experimental plague].
    Gremiakova TA; Amel'chenko VA; Anisimov GA
    Biull Eksp Biol Med; 1995 Jan; 119(1):54-7. PubMed ID: 7718805
    [No Abstract]   [Full Text] [Related]  

  • 25. Yersinia pestis F1 antigen: a correlation between antibody titres and subclass distribution with differential avidity in different inbred mouse strains.
    Sabhnani L; Manocha M; Tomar D; Shashikiran D; Rao DN
    Int Immunopharmacol; 2003 Oct; 3(10-11):1413-8. PubMed ID: 12946437
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plague immunization. VI. Vaccination with the fraction I antigen of Yersinia pestis.
    Meyer KF; Hightower JA; McCrumb FR
    J Infect Dis; 1974 May; 129():Suppl:S41-5. PubMed ID: 4825248
    [No Abstract]   [Full Text] [Related]  

  • 27. [The plague: disease and vaccine?].
    Michel P; Rasoamanana B; Rasolofonirina N; Roux J
    Dakar Med; 1992; 37(2):183-9. PubMed ID: 1345094
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of immune modulation on immunogenic and protective activity of a live plague vaccine].
    Karal'nik BV; Ponomareva TS; Deriabin PN; Denisova TG; Mel'nikova NN; Tugambaev TI; Atshabar BB; Zakarian SB
    Zh Mikrobiol Epidemiol Immunobiol; 2014; (6):108-12. PubMed ID: 25816525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reaction of macrophage disappearance as a method for the evaluation of cellular immunity in experimental plague.
    Vasilieva GI; Kisileva AK; Doroshenko YP; Pustovalov VL
    J Hyg Epidemiol Microbiol Immunol; 1992; 36(1):123-8. PubMed ID: 1619289
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A comparative study by immunoblotting of the serological response in white mice and guinea pigs inoculated against plague].
    Nekliaev VN; Gamleshko KhP; Rozhkov KK
    Zh Mikrobiol Epidemiol Immunobiol; 1995; (6):75-6. PubMed ID: 8553775
    [No Abstract]   [Full Text] [Related]  

  • 31. [Morphofunctional evaluation of the state of cells of APUD-system biomodel during anti-plague vaccine process].
    Bugorkova SA; Kutyreva VV
    Zh Mikrobiol Epidemiol Immunobiol; 2013; (4):49-55. PubMed ID: 24341215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Newly described cell type may prove valuable in development of plague vaccines against biowarfare.
    Expert Rev Vaccines; 2011 Mar; 10(3):259. PubMed ID: 21434794
    [No Abstract]   [Full Text] [Related]  

  • 33. [Immunogenicity of B-antigen in experimental plague and pseudotuberculosis].
    Byvalov AA; Krupin VV; Gavrilov KE
    Zh Mikrobiol Epidemiol Immunobiol; 2006; (3):49-53. PubMed ID: 16830590
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The isolation and characteristics of variant plague microbes not producing the capsular antigen].
    Gvozdenko NA; Ryzhkov VIu; Pavlovich NV
    Mikrobiol Zh (1978); 1990; 52(6):13-7. PubMed ID: 2097497
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plague immunization. IV. Clinical reactions and serologic response to inoculations of Haffkine and freeze-dried plague vaccine.
    Meyer KF; Smith G; Foster LE; Marshall JD; Cavanaugh DC
    J Infect Dis; 1974 May; 129():Suppl:S30-6. PubMed ID: 4825247
    [No Abstract]   [Full Text] [Related]  

  • 36. The natural history and incidence of Yersinia pestis and prospects for vaccination.
    Williamson ED; Oyston PCF
    J Med Microbiol; 2012 Jul; 61(Pt 7):911-918. PubMed ID: 22442294
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The expression of Fc gamma receptors on the surface of macrophages activated by a vaccinal strain of Yersinia pestis].
    Vasil'eva GI; Tkachenko LN; Doroshenko EP; Gamleshko KhP; Balatskaia TA
    Mikrobiol Zh (1978); 1990; 52(2):84-8. PubMed ID: 2142978
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Biological activity of the components of F1-antigen of Yersinia pestis].
    Kosse LV; Lebedeva SA; Cherniavskaia AS; Nekliaev VN; Markina OV; Morozova IV; Eremenko NS; Sal'nikova OI
    Zh Mikrobiol Epidemiol Immunobiol; 2006; (3):76-81. PubMed ID: 16830596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Entrapping of hydrophobized plague capsular antigen into large unilamellar liposomes].
    Zakrevskiĭ VI; Plekhanova NG; Smirnova VI
    Ukr Biokhim Zh (1978); 1989; 61(2):89-93. PubMed ID: 2728118
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Electrophoretic mobility and energy charge of the adenyl system of blood lymphocytes in guinea pigs immunized against plague with strain Yersinia pestis ev subcultures with different immunogenicity].
    Anisimova TI; Saiapina LV; Korsukov VN
    Zh Mikrobiol Epidemiol Immunobiol; 2005; (5):63-6. PubMed ID: 16279538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.